Studying IDH1/2 mutations in clear cell renal cell carcinomas (RCCs) demonstrated that IDH1 is mutated in only 4 of 833 cases (0.5%) and no IDH2 mutations [12, 13]. The gene discussed is IDH2; the disease is clear cell renal carcinoma.